 | • レポートコード：MRC2-11QY02292 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はα1プロテアーゼインヒビターのグローバル市場について調査・分析したレポートです。種類別（粉末、液体）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別α1プロテアーゼインヒビターの競争状況、市場シェア ・世界のα1プロテアーゼインヒビター市場：種類別市場規模 2015年-2020年（粉末、液体） ・世界のα1プロテアーゼインヒビター市場：種類別市場規模予測 2021年-2026年（粉末、液体） ・世界のα1プロテアーゼインヒビター市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のα1プロテアーゼインヒビター市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のα1プロテアーゼインヒビター市場分析：米国、カナダ ・ヨーロッパのα1プロテアーゼインヒビター市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのα1プロテアーゼインヒビター市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のα1プロテアーゼインヒビター市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのα1プロテアーゼインヒビター市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、Kamada、Talecris Biotherapeutics、Aventis、CSL Behring、Grifols ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Alpha1-Proteinase Inhibitor Market
The global Alpha1-Proteinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alpha1-Proteinase Inhibitor Scope and Market Size
Alpha1-Proteinase Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alpha1-Proteinase Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alpha1-Proteinase Inhibitor market is segmented into
Powder
Liquid
Segment by Application, the Alpha1-Proteinase Inhibitor market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Alpha1-Proteinase Inhibitor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alpha1-Proteinase Inhibitor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alpha1-Proteinase Inhibitor Market Share Analysis
Alpha1-Proteinase Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alpha1-Proteinase Inhibitor business, the date to enter into the Alpha1-Proteinase Inhibitor market, Alpha1-Proteinase Inhibitor product introduction, recent developments, etc.
The major vendors covered:
Baxter
Kamada
Talecris Biotherapeutics
Aventis
CSL Behring
Grifols
…
1 Study Coverage
1.1 Alpha1-Proteinase Inhibitor Product Introduction
1.2 Market Segments
1.3 Key Alpha1-Proteinase Inhibitor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type
1.4.2 Powder
1.4.3 Liquid
1.5 Market by Application
1.5.1 Global Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alpha1-Proteinase Inhibitor Market Size, Estimates and Forecasts
2.1.1 Global Alpha1-Proteinase Inhibitor Revenue 2015-2026
2.1.2 Global Alpha1-Proteinase Inhibitor Sales 2015-2026
2.2 Global Alpha1-Proteinase Inhibitor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alpha1-Proteinase Inhibitor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alpha1-Proteinase Inhibitor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alpha1-Proteinase Inhibitor Competitor Landscape by Players
3.1 Alpha1-Proteinase Inhibitor Sales by Manufacturers
3.1.1 Alpha1-Proteinase Inhibitor Sales by Manufacturers (2015-2020)
3.1.2 Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers (2015-2020)
3.2 Alpha1-Proteinase Inhibitor Revenue by Manufacturers
3.2.1 Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2015-2020)
3.2.2 Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alpha1-Proteinase Inhibitor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alpha1-Proteinase Inhibitor Revenue in 2019
3.2.5 Global Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alpha1-Proteinase Inhibitor Price by Manufacturers
3.4 Alpha1-Proteinase Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 Alpha1-Proteinase Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alpha1-Proteinase Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into Alpha1-Proteinase Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alpha1-Proteinase Inhibitor Market Size by Type (2015-2020)
4.1.1 Global Alpha1-Proteinase Inhibitor Sales by Type (2015-2020)
4.1.2 Global Alpha1-Proteinase Inhibitor Revenue by Type (2015-2020)
4.1.3 Alpha1-Proteinase Inhibitor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alpha1-Proteinase Inhibitor Market Size Forecast by Type (2021-2026)
4.2.1 Global Alpha1-Proteinase Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Alpha1-Proteinase Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Alpha1-Proteinase Inhibitor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alpha1-Proteinase Inhibitor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Alpha1-Proteinase Inhibitor Market Size by Application (2015-2020)
5.1.1 Global Alpha1-Proteinase Inhibitor Sales by Application (2015-2020)
5.1.2 Global Alpha1-Proteinase Inhibitor Revenue by Application (2015-2020)
5.1.3 Alpha1-Proteinase Inhibitor Price by Application (2015-2020)
5.2 Alpha1-Proteinase Inhibitor Market Size Forecast by Application (2021-2026)
5.2.1 Global Alpha1-Proteinase Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Alpha1-Proteinase Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Alpha1-Proteinase Inhibitor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Alpha1-Proteinase Inhibitor by Country
6.1.1 North America Alpha1-Proteinase Inhibitor Sales by Country
6.1.2 North America Alpha1-Proteinase Inhibitor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alpha1-Proteinase Inhibitor Market Facts & Figures by Type
6.3 North America Alpha1-Proteinase Inhibitor Market Facts & Figures by Application
7 Europe
7.1 Europe Alpha1-Proteinase Inhibitor by Country
7.1.1 Europe Alpha1-Proteinase Inhibitor Sales by Country
7.1.2 Europe Alpha1-Proteinase Inhibitor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alpha1-Proteinase Inhibitor Market Facts & Figures by Type
7.3 Europe Alpha1-Proteinase Inhibitor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Alpha1-Proteinase Inhibitor by Region
8.1.1 Asia Pacific Alpha1-Proteinase Inhibitor Sales by Region
8.1.2 Asia Pacific Alpha1-Proteinase Inhibitor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alpha1-Proteinase Inhibitor Market Facts & Figures by Type
8.3 Asia Pacific Alpha1-Proteinase Inhibitor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Alpha1-Proteinase Inhibitor by Country
9.1.1 Latin America Alpha1-Proteinase Inhibitor Sales by Country
9.1.2 Latin America Alpha1-Proteinase Inhibitor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alpha1-Proteinase Inhibitor Market Facts & Figures by Type
9.3 Central & South America Alpha1-Proteinase Inhibitor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Alpha1-Proteinase Inhibitor by Country
10.1.1 Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country
10.1.2 Middle East and Africa Alpha1-Proteinase Inhibitor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Alpha1-Proteinase Inhibitor Market Facts & Figures by Type
10.3 Middle East and Africa Alpha1-Proteinase Inhibitor Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Alpha1-Proteinase Inhibitor Products Offered
11.1.5 Baxter Related Developments
11.2 Kamada
11.2.1 Kamada Corporation Information
11.2.2 Kamada Description and Business Overview
11.2.3 Kamada Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Kamada Alpha1-Proteinase Inhibitor Products Offered
11.2.5 Kamada Related Developments
11.3 Talecris Biotherapeutics
11.3.1 Talecris Biotherapeutics Corporation Information
11.3.2 Talecris Biotherapeutics Description and Business Overview
11.3.3 Talecris Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Products Offered
11.3.5 Talecris Biotherapeutics Related Developments
11.4 Aventis
11.4.1 Aventis Corporation Information
11.4.2 Aventis Description and Business Overview
11.4.3 Aventis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aventis Alpha1-Proteinase Inhibitor Products Offered
11.4.5 Aventis Related Developments
11.5 CSL Behring
11.5.1 CSL Behring Corporation Information
11.5.2 CSL Behring Description and Business Overview
11.5.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CSL Behring Alpha1-Proteinase Inhibitor Products Offered
11.5.5 CSL Behring Related Developments
11.6 Grifols
11.6.1 Grifols Corporation Information
11.6.2 Grifols Description and Business Overview
11.6.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Grifols Alpha1-Proteinase Inhibitor Products Offered
11.6.5 Grifols Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Alpha1-Proteinase Inhibitor Products Offered
11.1.5 Baxter Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alpha1-Proteinase Inhibitor Market Estimates and Projections by Region
12.1.1 Global Alpha1-Proteinase Inhibitor Sales Forecast by Regions 2021-2026
12.1.2 Global Alpha1-Proteinase Inhibitor Revenue Forecast by Regions 2021-2026
12.2 North America Alpha1-Proteinase Inhibitor Market Size Forecast (2021-2026)
12.2.1 North America: Alpha1-Proteinase Inhibitor Sales Forecast (2021-2026)
12.2.2 North America: Alpha1-Proteinase Inhibitor Revenue Forecast (2021-2026)
12.2.3 North America: Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2021-2026)
12.3 Europe Alpha1-Proteinase Inhibitor Market Size Forecast (2021-2026)
12.3.1 Europe: Alpha1-Proteinase Inhibitor Sales Forecast (2021-2026)
12.3.2 Europe: Alpha1-Proteinase Inhibitor Revenue Forecast (2021-2026)
12.3.3 Europe: Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alpha1-Proteinase Inhibitor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alpha1-Proteinase Inhibitor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alpha1-Proteinase Inhibitor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alpha1-Proteinase Inhibitor Market Size Forecast by Region (2021-2026)
12.5 Latin America Alpha1-Proteinase Inhibitor Market Size Forecast (2021-2026)
12.5.1 Latin America: Alpha1-Proteinase Inhibitor Sales Forecast (2021-2026)
12.5.2 Latin America: Alpha1-Proteinase Inhibitor Revenue Forecast (2021-2026)
12.5.3 Latin America: Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alpha1-Proteinase Inhibitor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alpha1-Proteinase Inhibitor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alpha1-Proteinase Inhibitor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alpha1-Proteinase Inhibitor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alpha1-Proteinase Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Alpha1-Proteinase Inhibitor Market Segments
Table 2. Ranking of Global Top Alpha1-Proteinase Inhibitor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Powder
Table 5. Major Manufacturers of Liquid
Table 6. Global Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Alpha1-Proteinase Inhibitor Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Alpha1-Proteinase Inhibitor Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Alpha1-Proteinase Inhibitor Sales Market Share by Regions (2015-2020)
Table 10. Global Alpha1-Proteinase Inhibitor Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Alpha1-Proteinase Inhibitor Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Alpha1-Proteinase Inhibitor Sales Share by Manufacturers (2015-2020)
Table 13. Global Alpha1-Proteinase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Alpha1-Proteinase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha1-Proteinase Inhibitor as of 2019)
Table 15. Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Alpha1-Proteinase Inhibitor Price (2015-2020) (US$/Ton)
Table 18. Alpha1-Proteinase Inhibitor Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Alpha1-Proteinase Inhibitor Product Type
Table 20. Date of International Manufacturers Enter into Alpha1-Proteinase Inhibitor Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Alpha1-Proteinase Inhibitor Sales by Type (2015-2020) (Kiloton)
Table 23. Global Alpha1-Proteinase Inhibitor Sales Share by Type (2015-2020)
Table 24. Global Alpha1-Proteinase Inhibitor Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Alpha1-Proteinase Inhibitor Revenue Share by Type (2015-2020)
Table 26. Alpha1-Proteinase Inhibitor Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Alpha1-Proteinase Inhibitor Sales by Application (2015-2020) (Kiloton)
Table 28. Global Alpha1-Proteinase Inhibitor Sales Share by Application (2015-2020)
Table 29. North America Alpha1-Proteinase Inhibitor Sales by Country (2015-2020) (Kiloton)
Table 30. North America Alpha1-Proteinase Inhibitor Sales Market Share by Country (2015-2020)
Table 31. North America Alpha1-Proteinase Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2015-2020)
Table 33. North America Alpha1-Proteinase Inhibitor Sales by Type (2015-2020) (Kiloton)
Table 34. North America Alpha1-Proteinase Inhibitor Sales Market Share by Type (2015-2020)
Table 35. North America Alpha1-Proteinase Inhibitor Sales by Application (2015-2020) (Kiloton)
Table 36. North America Alpha1-Proteinase Inhibitor Sales Market Share by Application (2015-2020)
Table 37. Europe Alpha1-Proteinase Inhibitor Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Alpha1-Proteinase Inhibitor Sales Market Share by Country (2015-2020)
Table 39. Europe Alpha1-Proteinase Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2015-2020)
Table 41. Europe Alpha1-Proteinase Inhibitor Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Alpha1-Proteinase Inhibitor Sales Market Share by Type (2015-2020)
Table 43. Europe Alpha1-Proteinase Inhibitor Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Alpha1-Proteinase Inhibitor Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Alpha1-Proteinase Inhibitor Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Alpha1-Proteinase Inhibitor Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Alpha1-Proteinase Inhibitor Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Alpha1-Proteinase Inhibitor Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Alpha1-Proteinase Inhibitor Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Alpha1-Proteinase Inhibitor Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Alpha1-Proteinase Inhibitor Sales Market Share by Application (2015-2020)
Table 53. Latin America Alpha1-Proteinase Inhibitor Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Alpha1-Proteinase Inhibitor Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Alpha1-Proteinase Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2015-2020)
Table 57. Latin America Alpha1-Proteinase Inhibitor Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Alpha1-Proteinase Inhibitor Sales Market Share by Type (2015-2020)
Table 59. Latin America Alpha1-Proteinase Inhibitor Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Alpha1-Proteinase Inhibitor Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share by Application (2015-2020)
Table 69. Baxter Corporation Information
Table 70. Baxter Description and Major Businesses
Table 71. Baxter Alpha1-Proteinase Inhibitor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Baxter Product
Table 73. Baxter Recent Development
Table 74. Kamada Corporation Information
Table 75. Kamada Description and Major Businesses
Table 76. Kamada Alpha1-Proteinase Inhibitor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Kamada Product
Table 78. Kamada Recent Development
Table 79. Talecris Biotherapeutics Corporation Information
Table 80. Talecris Biotherapeutics Description and Major Businesses
Table 81. Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Talecris Biotherapeutics Product
Table 83. Talecris Biotherapeutics Recent Development
Table 84. Aventis Corporation Information
Table 85. Aventis Description and Major Businesses
Table 86. Aventis Alpha1-Proteinase Inhibitor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Aventis Product
Table 88. Aventis Recent Development
Table 89. CSL Behring Corporation Information
Table 90. CSL Behring Description and Major Businesses
Table 91. CSL Behring Alpha1-Proteinase Inhibitor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. CSL Behring Product
Table 93. CSL Behring Recent Development
Table 94. Grifols Corporation Information
Table 95. Grifols Description and Major Businesses
Table 96. Grifols Alpha1-Proteinase Inhibitor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Grifols Product
Table 98. Grifols Recent Development
Table 99. Global Alpha1-Proteinase Inhibitor Sales Forecast by Regions (2021-2026) (Kiloton)
Table 100. Global Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Alpha1-Proteinase Inhibitor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Alpha1-Proteinase Inhibitor Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Alpha1-Proteinase Inhibitor Sales Forecast by Country (2021-2026) (Kiloton)
Table 104. North America: Alpha1-Proteinase Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Alpha1-Proteinase Inhibitor Sales Forecast by Country (2021-2026) (Kiloton)
Table 106. Europe: Alpha1-Proteinase Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Alpha1-Proteinase Inhibitor Sales Forecast by Region (2021-2026) (Kiloton)
Table 108. Asia Pacific: Alpha1-Proteinase Inhibitor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Alpha1-Proteinase Inhibitor Sales Forecast by Country (2021-2026) (Kiloton)
Table 110. Latin America: Alpha1-Proteinase Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Alpha1-Proteinase Inhibitor Sales Forecast by Country (2021-2026) (Kiloton)
Table 112. Middle East and Africa: Alpha1-Proteinase Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Alpha1-Proteinase Inhibitor Players
Table 117. Alpha1-Proteinase Inhibitor Customers List
Table 118. Alpha1-Proteinase Inhibitor Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha1-Proteinase Inhibitor Product Picture
Figure 2. Global Alpha1-Proteinase Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Powder Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Alpha1-Proteinase Inhibitor Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Alpha1-Proteinase Inhibitor Report Years Considered
Figure 9. Global Alpha1-Proteinase Inhibitor Market Size 2015-2026 (US$ Million)
Figure 10. Global Alpha1-Proteinase Inhibitor Sales 2015-2026 (Kiloton)
Figure 11. Global Alpha1-Proteinase Inhibitor Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Alpha1-Proteinase Inhibitor Sales Market Share by Region (2015-2020)
Figure 13. Global Alpha1-Proteinase Inhibitor Sales Market Share by Region in 2019
Figure 14. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2015-2020)
Figure 15. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Region in 2019
Figure 16. Global Alpha1-Proteinase Inhibitor Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Alpha1-Proteinase Inhibitor Revenue in 2019
Figure 18. Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Alpha1-Proteinase Inhibitor Sales Market Share by Type (2015-2020)
Figure 20. Global Alpha1-Proteinase Inhibitor Sales Market Share by Type in 2019
Figure 21. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2015-2020)
Figure 22. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Type in 2019
Figure 23. Global Alpha1-Proteinase Inhibitor Market Share by Price Range (2015-2020)
Figure 24. Global Alpha1-Proteinase Inhibitor Sales Market Share by Application (2015-2020)
Figure 25. Global Alpha1-Proteinase Inhibitor Sales Market Share by Application in 2019
Figure 26. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2015-2020)
Figure 27. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Application in 2019
Figure 28. North America Alpha1-Proteinase Inhibitor Sales Growth Rate 2015-2020 (Kiloton)
Figure 29. North America Alpha1-Proteinase Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Alpha1-Proteinase Inhibitor Sales Market Share by Country in 2019
Figure 31. North America Alpha1-Proteinase Inhibitor Revenue Market Share by Country in 2019
Figure 32. U.S. Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. U.S. Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. Canada Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Alpha1-Proteinase Inhibitor Market Share by Type in 2019
Figure 37. North America Alpha1-Proteinase Inhibitor Market Share by Application in 2019
Figure 38. Europe Alpha1-Proteinase Inhibitor Sales Growth Rate 2015-2020 (Kiloton)
Figure 39. Europe Alpha1-Proteinase Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Alpha1-Proteinase Inhibitor Sales Market Share by Country in 2019
Figure 41. Europe Alpha1-Proteinase Inhibitor Revenue Market Share by Country in 2019
Figure 42. Germany Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 43. Germany Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. France Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. U.K. Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. Italy Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. Russia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Alpha1-Proteinase Inhibitor Market Share by Type in 2019
Figure 53. Europe Alpha1-Proteinase Inhibitor Market Share by Application in 2019
Figure 54. Asia Pacific Alpha1-Proteinase Inhibitor Sales Growth Rate 2015-2020 (Kiloton)
Figure 55. Asia Pacific Alpha1-Proteinase Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Alpha1-Proteinase Inhibitor Sales Market Share by Region in 2019
Figure 57. Asia Pacific Alpha1-Proteinase Inhibitor Revenue Market Share by Region in 2019
Figure 58. China Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. China Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Japan Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 63. South Korea Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. India Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 67. Australia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Taiwan Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 71. Indonesia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Thailand Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 75. Malaysia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. Philippines Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 79. Vietnam Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Alpha1-Proteinase Inhibitor Market Share by Type in 2019
Figure 81. Asia Pacific Alpha1-Proteinase Inhibitor Market Share by Application in 2019
Figure 82. Latin America Alpha1-Proteinase Inhibitor Sales Growth Rate 2015-2020 (Kiloton)
Figure 83. Latin America Alpha1-Proteinase Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Alpha1-Proteinase Inhibitor Sales Market Share by Country in 2019
Figure 85. Latin America Alpha1-Proteinase Inhibitor Revenue Market Share by Country in 2019
Figure 86. Mexico Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 87. Mexico Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 89. Brazil Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 91. Argentina Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Alpha1-Proteinase Inhibitor Market Share by Type in 2019
Figure 93. Latin America Alpha1-Proteinase Inhibitor Market Share by Application in 2019
Figure 94. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Growth Rate 2015-2020 (Kiloton)
Figure 95. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue Market Share by Country in 2019
Figure 98. Turkey Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 99. Turkey Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 101. Saudi Arabia Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Alpha1-Proteinase Inhibitor Sales Growth Rate (2015-2020) (Kiloton)
Figure 103. UAE Alpha1-Proteinase Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Alpha1-Proteinase Inhibitor Market Share by Type in 2019
Figure 105. Middle East and Africa Alpha1-Proteinase Inhibitor Market Share by Application in 2019
Figure 106. North America Alpha1-Proteinase Inhibitor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 107. North America Alpha1-Proteinase Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Alpha1-Proteinase Inhibitor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 109. Europe Alpha1-Proteinase Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Alpha1-Proteinase Inhibitor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 111. Asia Pacific Alpha1-Proteinase Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Alpha1-Proteinase Inhibitor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 113. Latin America Alpha1-Proteinase Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 115. Middle East and Africa Alpha1-Proteinase Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
プロテイナーゼ活性化受容体2の世界市場（～2026年） Market Analysis and Insights: Global Proteinase Activated Receptor 2 Market The global Proteinase Activated Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Proteinase Activated Receptor 2 Scope and Market Si…- 血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
- プラスミノーゲンアクチベーター阻害剤1の世界市場（～2026年） Market Analysis and Insights: Global Plasminogen Activator Inhibitor 1 Market The global Plasminogen Activator Inhibitor 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Plasminogen Activator Inhibitor 1 Scope and Mar…
- IDO阻害剤の世界市場（～2026年） Market Analysis and Insights: Global IDO inhibitor Market The global IDO inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global IDO inhibitor Scope and Market Size IDO inhibitor market is segmented by Type, and by A…
- 核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Inh…